Clinical Evidence And ValidationExtensive published clinical evidence indicates the technology reduces unnecessary invasive procedures and leads physicians to change patient management, supporting stronger clinician adoption and payer confidence.
Proprietary Data AdvantageA large, proprietary library of coronary CT scans assembled through extensive clinical work creates a barrier that is difficult for competitors to reproduce, protecting algorithm performance and commercial differentiation.
Reimbursement And Coverage ExpansionPermanent coding and expanding coverage for plaque analysis create stronger economic incentives that should enable broader adoption among clinicians already using the company's noninvasive physiological assessment services.